S. O. Maguiraga

Artemether-lumefantrine with or without single-dose primaquine and sulfadoxine-pyrimethamine plus amodiaquine with or without single-dose tafenoquine to reduce Plasmodium falciparum transmission: a phase 2, single-blind, randomised clinical trial in Ouelessebougou, Mali.

A. Dicko, T. Bousema, S. Traore, 2024, The Lancet. Microbe.

Single low-dose tafenoquine combined with dihydroartemisinin–piperaquine to reduce Plasmodium falciparum transmission in Ouelessebougou, Mali: a phase 2, single-blind, randomised clinical trial

A. Dicko, T. Bousema, C. Drakeley, 2022, The Lancet. Microbe.

Artemether-lumefantrine-amodiaquine or artesunate-amodiaquine combined with single low-dose primaquine to reduce Plasmodium falciparum malaria transmission in Ouelessebougou, Mali: a five-arm, phase 2, single-blind, randomised clinical trial

A. Dondorp, K. Teelen, S. M. Niambele, 2024, medRxiv.

Safety and efficacy of malaria vaccine candidate R21/Matrix-M in African children: a multicentre, double-blind, randomised, phase 3 trial

A. Dicko, A. Olotu, H. Tinto, 2024, The Lancet.